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Suppression of  Cell Energy Metabolism
and Insulin Release by PGC-1
Introduction
The cardinal triad of metabolic disturbances in type 2
J. Cliff Yoon,1 Gang Xu,2 Jude T. Deeney,3
Shao-Nian Yang,4 James Rhee,1 Pere Puigserver,1
Adah R. Levens,1 Ruojing Yang,5 Chen-Yu Zhang,6
diabetes includes diminished insulin-stimulated glucoseBradford B. Lowell,6 Per-Olof Berggren,4
uptake by skeletal muscle and fat, increased hepaticChristopher B. Newgard,5 Susan Bonner-Weir,2
glucose production, and impaired insulin secretion byGordon Weir,2 and Bruce M. Spiegelman1,*
pancreatic  cells (reviewed in DeFronzo, 1997). Human1Dana-Farber Cancer Institute and
diabetic subjects ultimately develop profound insulinDepartment of Cell Biology
secretory defects in islets, including loss of the earlyHarvard Medical School
response to intravenous glucose, delayed and blunted2 Section of Islet Transplantation and Cell Biology
responses to mixed nutrient meals, and alterations in theJoslin Diabetes Center
normal pulsatile pattern of insulin secretion (reviewed inHarvard Medical School
Evans and Krentz, 2001; Kahn, 2001; Bell and Polonsky,Boston, Massachusetts 02215
2001). While the molecular mechanisms underlying the3 Obesity Research Center
 cell dysfunction in diabetes remain obscure and areDepartment of Medicine
rather difficult to study in humans, animal models haveBoston University School of Medicine
revealed a multitude of changes in gene expression inBoston, Massachusetts 02118
islets that are associated with progression of disease4 The Rolf Luft Center for Diabetes Research
(Johnson et al., 1990; Tokuyama et al., 1995; Laybutt etDepartment of Molecular Medicine
al., 2002). It has been convincingly shown that impairedKarolinska Institute
insulin secretion in vivo coincides with major alterationsSE-171 76, Stockholm
in carbohydrate and lipid metabolism in the  cell.Sweden
The principal connection between altered  cell me-5 Sarah W. Stedman Center
tabolism and abnormal insulin secretion derives fromfor Nutritional Studies and
the widely accepted model of insulin release, in whichDepartment of Pharmacology and Cancer Biology
glucose metabolism and the subsequent rise in the cel-Duke University Medical Center
lular ATP/ADP ratio constitutes a major signal that trig-Durham, North Carolina 27710
gers the insulin secretory cascade (reviewed in Newgard6 Division of Endocrinology and
and McGarry, 1995; Deeney et al., 2000). The closure ofDepartment of Medicine
the ATP-sensitive K channel in response to rising ATPBeth Israel Deaconess Medical Center and
levels causes membrane depolarization and subsequentHarvard Medical School
activation of voltage-sensitive Ca2 channels. Ulti-Boston, Massachusetts 02215
mately, the influx of Ca2 leads to formation of the core
complex of exocytosis proteins and activation of protein
kinases, which then mediate exocytosis of insulin.
Summary Islets from diabetic animals display significant defects
in glucose oxidation associated with a reduction in the
expression of GLUT2, the  cell glucose transporter, cell dysfunction is an important component of type
and certain enzymes of glucose catabolism, including2 diabetes, but the molecular basis for this defect is
glucokinase and glycerol-3-phosphate dehydrogenase,poorly understood. The transcriptional coactivator
and an increase in glucose-6-phosphatase (Johnson etPGC-1mRNA and protein levels are significantly ele-
al., 1990; Tokuyama et al., 1995; Laybutt et al., 2002;vated in islets from multiple animal models of diabetes;
Newgard and Matschinsky, 2001; Khan et al., 1989,adenovirus-mediated expression of PGC-1 to levels
1990; Chan et al., 1996; Ostenson et al., 1993; Fabregatsimilar to those present in diabetic rodents produces
et al., 1996; MacDonald et al., 1996). The resulting in-a marked inhibition of glucose-stimulated insulin se-
crease in nonproductive glucose cycling and decreasecretion from islets in culture and in live mice. This
in glucose catabolism are associated with reduced cel-inhibition coincides with changes in metabolic gene
lular ATP/ADP ratios. In addition, there is an elevationexpression associated with impaired  cell function,
of uncoupling protein-2 (UCP-2) in the  cells of obeseincluding the induction of glucose-6-phosphatase and
mice (Zhang et al., 2001). Genetic data indicates thatsuppression of GLUT2, glucokinase, and glycerol-3-
the increase in the uncoupling of mitochondrial oxidativephosphate dehydrogenase. These changes result in
phosphorylation leads to a fall in insulin secretion (Zhangblunting of the glucose-induced rise in cellular ATP
et al., 2001). Thus, multiple abnormalities in several keylevels and membrane electrical activity responsible
steps governing glucose and energy metabolism in thefor Ca2 influx and insulin exocytosis. These results
cell may act in concert to suppress the nutrient-derivedstrongly suggest that PGC-1 plays a key functional
intracellular signals in the setting of diabetes.role in the  cell and is involved in the pathogenesis
PGC-1 is a highly regulated transcriptional coactiva-of the diabetic phenotype.
tor of nuclear receptors and other transcription factors
that has been linked to the control of energy metabolism
in multiple cell types (Puigserver et al., 1998; Wu et al.,*Correspondence: bruce_spiegelman@dfci.harvard.edu
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1999; Lehmann, et al., 2000; Yoon et al., 2001; Herzig cell insufficiency associated with type 2 and early type
1 diabetes (Laybutt et al., 2002). The  cell dysfunction inet al., 2001; Michael et al., 2001; Lin et al., 2002). While
our original studies showed that PGC-1 could increase this model likely originates from environmental triggers
different from those of obese congenital models suchmitochondrial biogenesis and uncoupling in brown fat
and muscle (Puigserver et al., 1998; Wu et al., 1999), as ZDF rats or ob/ob mice, but they share common
functional abnormalities in insulin secretion. PGC-1more recent studies have illustrated a role for this coacti-
vator in muscle fiber-type switching and glucose metab- mRNA levels were elevated 3-fold in islets from 90%
pancreatectomized rats compared to the controls at 2olism in the liver (Yoon et al., 2001; Herzig et al., 2001;
Lin et al., 2002). Specifically, PGC-1 is a very potent and 4 weeks following surgery (Figure 1D). This elevation
also correlated temporally with increases in glucose-stimulator of hepatic gluconeogenesis in cultured cells
and in livers of intact rats, providing a molecular frame- 6-phosphatase gene expression (Laybutt et al., 2002).
Thus, islet PGC-1 expression is consistently inducedwork for the transcriptional regulation of this process
(Yoon et al., 2001; Herzig et al., 2001). PGC-1 is ele- in several very distinct models of diabetes, both genetic
and nongenetic, that are associated with prominent vated in the liver in fasting and in diabetes, and increases
hepatic glucose output by inducing an array of key glu- cell secretory defects.
coneogenic enzymes, including phosphoenolpyruvate
carboxykinase (PEPCK), fructose-1,6-bisphosphatase, PGC-1 Negatively Regulates Insulin Secretion
and glucose-6-phosphatase. This linkage with glucose in Islets and  Cell Lines
metabolism motivated an examination of a possible role To investigate the effects of PGC-1 on glucose-stimu-
for PGC-1 in the  cell. lated insulin secretion in the  cell, this protein was
We show here that the islet PGC-1 levels are mark- expressed in isolated rat islets using an adenoviral vec-
edly elevated in diabetic animals with defective insulin tor. A multiplicity of infection (moi) of 30 was sufficient
secretion. Expression of this coactivator at levels ap- to achieve a high-efficiency transduction (60%–70%) of
proximating those found in islets of diabetic animal lev- intact pancreatic islets, with good penetration into the
els results in suppression of glucose-induced insulin core, as determined by confocal microscopic detection
release from islets in culture and in mice following trans- of the GFP marker gene expression (data not shown).
plantation. This occurs with an altered expression of Perifusion experiments with islets infected with the con-
metabolic genes in a pattern that bears a remarkable trol adenovirus showed that, as expected, insulin re-
resemblance to that seen in type 2 diabetes. These data lease was stimulated 4- to 5-fold by a step increase in
strongly suggest that PGC-1 plays an important role in the glucose concentration in the perifusion buffer from
the pathogenesis of cell dysfunction in type 2 diabetes. 3 to 16.7 mM (Figure 2). In a series of three separate
experiments, PGC-1 expression caused a decrease in
glucose-stimulated insulin secretion ranging from a 40%Results
reduction to a complete abolishment of response, with
an average of approximately 60%. Two representativePGC-1 Is Expressed in Pancreatic Islets and
Elevated in Animal Models of Type 2 Diabetes experiments are shown in Figure 2. PGC-1mRNA levels
were elevated approximately 7-fold in these experi-We examined the expression of PGC-1 in isolated pan-
creatic islets and transformed  cells (INS-1) by real- ments (Figure 3A). The basal secretion in 3 mM glucose
was often slightly higher in PGC-1-expressing islets,time reverse transcription-polymerase chain reaction
(RT-PCR). Both insulinoma cells and pancreatic islets but both the early and the delayed phases of insulin
secretion were negatively affected following glucoseexpressed PGC-1 at 30%–40% of the levels found in
liver from ad libitum fed mice (Figure 1A). We also as- stimulation (Figure 2), reminiscent of the secretory pat-
terns that characterize type 2 diabetes. PGC-1 alsosessed PGC-1 expression in animal models of type 2
diabetes associated with impaired  cell function, such caused a dampening of the oscillatory patterns in insulin
secretion that normally occurs with a period of roughlyas Zucker diabetic fatty (ZDF) rats and ob/ob mice. At
9 weeks and 3 months respectively, the ZDF rats and 5–10 min, both in isolated islets and in vivo (Tornheim,
1997; O’Rahilly et al., 1998). Importantly, no significantob/ob mice are overtly diabetic, but the  cells are still
predominantly in a hyperplastic phase. As shown in pre- difference was seen in the magnitude of the secretory
response when depolarizing concentrations of KCl (40vious studies (Tokuyama et al., 1995), islets from the
ZDF rat have elevated gene expression for the catalytic mM) was used to induce basic exocytosis of insulin-
containing secretory granules (Figure 2, Experiment A),subunit of glucose-6-phosphatase (shared by liver and
 cells) and reduced glucokinase and GLUT2 (Figure indicating that the exocytosis machinery remained in-
tact in PGC-1-expressing islets. The insulin contents,1B). Interestingly, the islet PGC-1 levels were found to
be significantly elevated in ZDF rats and ob/ob mice, extracted at the end of the secretion experiment, were
only modestly decreased (roughly 15%) in PGC-1both at the mRNA and protein levels (Figures 1B and
1C). The PGC-1 mRNA levels were increased 3- to -expressing islets compared to the control (7.2  0.6
versus 6.2  0.5 ng/islet.ml). These results show that4-fold in the obese, diabetic models compared to the
control animals, while the protein levels were elevated PGC-1 can, at levels observed in diabetes, suppress
glucose-induced insulin release without affecting theto an even greater extent, 5-fold in ZDF and 11-fold in
ob/ob mice. Another model of  cell decompensation basic secretory apparatus.
Similar results were obtained with the INS-1-derivedis partial pancreatectomy (approximately 90%) which,
following a 7–10 day period of limited recovery, stably cell line 832/13, which displays a particularly robust re-
sponse to glucose stimulation (Hohmeier et al., 2000).reproduces the chronic hyperglycemia and relative 
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Figure 1. Expression of PGC-1 in Pancreatic Islets
(A) Relative abundance of PGC-1 transcript in selected tissues and cell lines. Total RNA was extracted from pooled male mouse tissues
(n  3–5) or cell lines, and 1 g per tissue was used for reverse transcription, followed by real-time PCR.
(B) Gene expression changes in islets from diabetic ZDF rats. Total RNA was extracted from pooled islets and subjected to real-time RT-PCR
as in (A).
(C) Elevation of PGC-1 in islets from diabetic animals. Protein extracts were made from pooled islets isolated from 9-week-old male rats
(ZDF fa/fa rats or / lean littermates) or 3-month-old mice (/ and ob/ob mice) and analyzed by immunoblotting for PGC-1. Animals
were fed a diet with fat constituting 4.5%–6% of total calories. Both the ZDF rats (serum glucose 300–500 mg/dl) and the ob/ob mice (200–350
mg/dl) were overtly diabetic at the time of sacrifice.
(D) Elevation of PGC-1 mRNA in islets from pancreatectomized rats. Male rats were subjected to 90% partial pancreatectomy (PPx) or sham
surgery. Islets were isolated at 1, 2, and 4 weeks after surgery and the mRNA levels determined by RT-PCR as previously described (Laybutt
et al., 2002).
PGC-1 expression via adenoviral vectors also caused these changes in GLUT2, glucokinase, glycerol-3-phos-
phate dehydrogenase, and glucose-6-phosphatasea clear inhibition of insulin secretion in these cells (data
not shown). transcript levels produced by PGC-1 expression
closely mirror those described in the context of  cellTo investigate the molecular basis of impaired insulin
secretion caused by PGC-1, we used intact islets to dysfunction in the islets of obese, diabetic ZDF rats
(Johnson et al., 1990; Tokuyama et al., 1995). UCP-2examine the levels of mRNAs encoding several  cell
genes involved in nutrient metabolism essential for insu- mRNA, which has been shown to be elevated in obese,
diabetic mice (Zhang et al., 2001), was unchanged bylin secretion. PGC-1 expression led to a large increase
(7-fold) in the mRNA encoding the catalytic subunit of PGC-1 expression.
Expression of PGC-1 in islets also reduced the levelsglucose-6-phosphatase, while reducing glucokinase by
approximately 75% and GLUT2 by more than 50% (Fig- of several islet-enriched transcription factors important
for  cell development and function, including HNF-4,ure 3A). In contrast, hexokinase, which has a lower KM for
glucose than glucokinase, was expressed at a slightly HNF-1, and PDX-1 (Figure 3B). Mutations in these tran-
scription factors are also associated with the MODY1,higher level. PGC-1 also decreased glycerol-3-phos-
phate dehydrogenase mRNA by 40%. It is striking that 3, and 4 syndromes, respectively, whereas the MODY2
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mediator of insulin exocytosis (reviewed in Newgard and
McGarry, 1995; Deeney et al., 2000). To critically evalu-
ate the possibility that PGC-1 can modulate this key
step in glucose-induced insulin release, we performed
patch-clamp recordings of glucose-induced electrical
activity in isolated mouse  cells subjected to infection
with an adenovirus expressing the control GFP protein
(Figure 4A, upper trace) or PGC-1 (lower trace). Resting
membrane potential did not differ between cells ex-
pressing GFP or PGC-1 during perifusion with 3 mM
glucose (Figure 4B). However, when challenged with
16.7 mM glucose, PGC-1-expressing  cells exhibited
significantly less frequent spikes of action potentials
than control cells (Figures 4A and 4C). These data
strongly suggest that PGC-1 controls  cell insulin se-
cretion, at least in part, by modulating the key metabolic
and ionic events leading up to membrane depolarization
and insulin exocytosis.
Ectopic Expression of Glucose-6-Phosphatase
Mimics the PGC-1-Mediated Inhibition of
Insulin Secretion while Restoration of
Glucokinase Partially Ameliorates the PGC-1 Effect
Elevated islet glucose-6-phosphatase activity has been
implicated in defective insulin secretion in diabetic and
obese hyperglycemic animals (Tokuyama et al., 1995;
Figure 2. Suppression of Insulin Secretion by PGC-1 Expression Khan et al., 1989, 1990; Chan et al., 1996; Ostenson et
in Islets
al., 1993). Because PGC-1 strongly induced glucose-
Isolated rat islets were infected with either GFP- or PGC- 6-phosphatase gene expression, we investigated the
1-expressing adenovirus. Perifusion studies were performed 48–72
possibility that the suppression of insulin secretion ob-hr after infection with a step increase in the glucose concentration
served here may be influenced by activation of this genein the perifusion buffer from 3 to 16.7 mM at the times indicated by
the arrows. and the consequent increase in futile glucose cycling.
Isolated rat islets were infected with either control ade-
novirus or those expressing PGC-1 or glucose-6-phos-
phatase (Trinh et al., 1997). As expected, expression ofgene encodes the enzyme glucokinase (Shih and Stoffel,
2001). Because these transcription factors themselves PGC-1 at an moi of 30 in islets led to a substantial
attenuation of insulin secretion at stimulatory concentra-may target GLUT2 and a subset of the glycolytic genes,
it is conceivable that PGC-1may act through suppres- tions of glucose, on average reducing the total insulin
output by about 60%. Expression of hepatic glucose-sion of these transcription factors. In contrast, the tran-
scription factor Sp1, which is present in all cell types, 6-phosphatase at an moi of 60 resulted in levels of this
mRNA comparable to those produced by PGC-1 ex-was not affected by PGC-1 expression.
The altered expression of metabolic genes in PGC- pression (Figure 5A). Interestingly, this degree of glu-
cose-6-phosphatase expression in islets mimicked the1-expressing islets may ultimately influence glucose-
induced fluctuations in cellular ATP levels, which in turn effect of PGC-1 to a significant extent, producing a
significant decrease in glucose-stimulated insulin re-are coupled to stimulation of insulin release. As ex-
pected, ATP levels were significantly increased in con- lease (Figure 5B). This result is also consistent with pre-
trol islets when the glucose concentration was stepped vious data obtained by overexpression of glucose-6-
up from 3 to 16.7 mM. While islets expressing ectopic phosphatase in insulinoma cell lines (Trinh et al., 1997;
PGC-1 had slightly higher basal ATP levels compared Fulceri et al., 2000; Iizuka et al., 2000).
to the controls, little further increase was induced by Similar experiments were performed with an adenovi-
exposure to high glucose concentrations (Figure 3C). ral vector expressing glucokinase, which allowed us to
These results suggest that the blunting of glucose-stim- attenuate the drop in the glucokinase mRNA caused by
ulated insulin secretion in PGC-1-expressing islets PGC-1. Glucokinase controls the rate-limiting step of
may be a consequence of diminished ability to drive glycolysis, serving as the  cell glucose sensor, and
ATP production in response to glucose stimulation. experimental attenuation of glucokinase impairs insulin
secretion in isolated islets and in vivo (Efrat et al., 1994;
Piston et al., 1999). Ectopic expression of glucokinasePGC-1 Suppresses Membrane Depolarization
with the control GFP protein did not appear to havein the  Cell
a major impact on the secretion profile, as reportedChanges in the rate of cellular ATP production can im-
previously (Becker et al., 1996). However, coexpressionpact upon insulin secretion by controlling  cell mem-
brane depolarization and influx of Ca2, the ultimate of glucokinase with PGC-1 essentially eliminated the
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Figure 3. Effect of PGC-1 on the  Cell Metabolic Gene Expression and ATP Production
(A) PGC-1 regulates enzymes of glucose sensing and cycling. Total RNA was prepared from isolated rat islets infected with GFP or PGC-1
 adenovirus and was subjected to real-time RT-PCR. *p  0.05; **p  0.01 versus GFP for each gene.
(B) Effects of PGC-1 expression on islet transcription factors. Total RNA was extracted from islets and was subjected to real-time RT-PCR
as in (A). *p  0.05 versus GFP for each gene.
(C) PGC-1 blunts glucose-induced increase in ATP production. Adenovirally infected rat islets were cultured overnight and incubated in 3
or 16.7 mM glucose for 1 hr. Islets were then extracted and the ATP concentrations measured by a luminometric assay. *p  0.05 versus 3
mM glucose.
drop in glucokinase expression that accompanies PGC- the transgene in grafts for over 4 weeks (Kaneto et al.,
1 expression (Figure 5C). This led to a significant im- 2002). Isolated rat islets were infected with viruses con-
provement in insulin secretion at stimulatory glucose taining the cDNA for PGC-1 or GFP, and transplanted
concentrations (Figure 5D), showing that suppression under renal capsules of STZ-induced diabetic mice. The
of glucose phosphorylation constitutes an additional islet grafts remained viable and similar in size and ap-
mechanism by which PGC-1 regulates the metabolic pearance at 2 and 4 weeks, but with altered patterns of
response in the  cell. These results, taken together, gene expression (data not shown and below). Weekly
strongly suggest that major perturbations in  cell glu- measurements of nonfasting blood glucose levels re-
cose sensing and metabolism underlie the observed vealed that animals that received transplants of GFP-
effect of PGC-1 on insulin secretion. expressing islets were able to normalize glucose levels
within 1 week, while those receiving the PGC-1-
expressing islets remained diabetic (Figure 6A). ThesePGC-1 Modulates the Antidiabetic Effects
changes correlated with greatly reduced insulin levelsof Islet Transplantion In Vivo
in mice receiving the PGC-1-expressing islets (FigureWe investigated the role of PGC-1 in  cell function in
6B). Intraperitoneal glucose tolerance test administeredvivo through transplantation studies. Transplantation of
at the end of 4 weeks demonstrated a persistently im-500–1000 islets under kidney capsules of mice rendered
paired response to a glucose load in the PGC-1 groupdiabetic through injection of the  cell toxin streptozo-
and a normal response in the GFP group (Figures 6Ctocin (STZ) has been shown to be sufficient for normal-
and 6D). There was no significant difference in weightization of glucose levels in these animals (Kaneto et al.,
gain between the two groups over the 4 week period2002). Adenoviral infection of islets prior to transplanta-
tion has been shown to result in robust expression of (data not shown).
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Figure 4. PGC-1 Expression Decreases  Cell Action Potential Frequency
(A) Examples of membrane potential traces recorded from a control cell (Ad GFP infection, upper) and a cell infected with Ad PGC-1 (lower).
Action potential in the cell infected with Ad PGC-1 fired at a markedly slower rate than that in the cell subjected to Ad GFP infection.
(B) No significant difference in the resting membrane potential was detected between control cells (n  14) and cells infected with Ad PGC-1
(n  14).
(C) Summary graph shows that cells infected with Ad PGC-1 (n  14) displayed a significantly slower action potential firing rate than control
cells (n  14). *p  0.05 versus Ad GFP.
We also analyzed the correlative changes in gene ex- influx, triggering exocytosis of insulin (reviewed in
Newgard and McGarry, 1995; Deeney et al., 2000). Be-pression at the end of the 4 week experiment by excising
the islet grafts from the animals. The grafts taken from cause the secretion of insulin is tightly coupled to the
rate of glucose metabolism, defects in the regulation ofthe PGC-1 group showed a persistent elevation of
PGC-1 and glucose-6-phosphatase mRNA levels, av- glucose oxidation in the  cell, such as reduced activity
of glycolytic enzymes and increased glucose cycling,eraging a 3.2- and 3.9-fold elevation at 4 weeks com-
pared to the GFP group (Figure 6E). UCP-2 mRNA, which have been viewed as key contributory factors in impair-
ment of insulin secretion (Johnson et al., 1990; Toku-was not elevated immediately following PGC-1 expres-
sion in culture, was increased 2.2-fold at 4 weeks follow- yama et al., 1995; Khan et al., 1989, 1990; Chan et al.,
1996; Ostenson et al., 1993; Trinh et al., 1997). Geneticing transplantation. Certain other islet genes, such as
hexokinase, did not differ appreciably between the two evidence for this comes from patients carrying muta-
tions in glucokinase, who exhibit defective insulin secre-groups, mirroring the results from cultured islets. These
data demonstrate that elevation of PGC-1 levels in the tion in one of the MODY forms of diabetes (Froguel et
al., 1992). The notions have been further supported byrange observed in diabetes can alter islet gene expres-
sion and markedly impair insulin secretion in vivo, likely a mathematical model of  cell glucose metabolism and
insulin release (Sweet and Matschinsky, 1995), but acontributing to glucose intolerance and overt diabetes
mellitus. unifying mechanistic basis for the multiple enzymatic
changes observed in diabetic islets has not been eluci-
dated.Discussion
It is shown here that the transcriptional coactivator
PGC-1, found at elevated levels in the islets of multipleGlucose-stimulated insulin release by  cells is a
multistep process that begins with glucose entry and models of diabetes, alters expression of several key
genes of  cell nutrient metabolism in a pattern thatmetabolism, causing a rise in the cellular ATP/ADP ratio.
The closure of the ATP-dependent K channel and sub- is remarkably similar to that seen in diabetic animals.
PGC-1 profoundly impairs glucose-stimulated insulinsequent membrane depolarization then leads to Ca2
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Figure 5. Glucose-6-Phosphatase Expression Mimicks PGC-1 Activity, and Restoration of Glucokinase Partially Ameliorates the Insulin
Secretion Defect in PGC-1-Expressing Islets
(A) Expression of glucose-6-phosphatse gene in islets. Isolated islets were infected with either control, PGC-1, or glucose-6-phosphatase
adenovirus, and total RNA was prepared for analysis of gene expression by real-time RT-PCR.
(B) Measurement of insulin release from glucose-6-phosphatase-expressing islets. Glucose-stimulated insulin release was measured from
batches of islets by incubating in basal Krebs buffer (3 mM glucose) and then adding basal or stimulation buffer (16.7 mM). Insulin content
of the culture media was measured by ELISA.
(C) Restoration of glucokinase mRNA by adenoviral infection. Isolated rat islets were infected with either GFP or PGC-1 adenovirus, followed
by a second infection with either -gal or GK adenovirus. Total RNA was prepared from islets and analyzed by real-time RT-PCR as in (A).
(D) Measurement of insulin release. Batches of infected islets were incubated in basal Krebs buffer (3 mM glucose) followed by basal or
stimulation buffer (16.7 mM), and secreted insulin was measured as in (B). *p  0.05; **p  0.01 versus Ad GFP  Ad -gal.
secretion, at least in part, as a result of these changes triggers the induction of PGC-1 in diabetes is presently
unknown, it could be related to the relative deficiencyin metabolic enzymes. It is important to note that the
effects observed through PGC-1 expression occur at in insulin signaling that characterizes all of the animal
models of diabetes used in these studies. We have pre-levels that approximate the levels actually observed in
diabetic islets. While the calculations of relative PGC-1 viously shown that PGC-1 is negatively regulated (al-
beit indirectly) by insulin in the liver (Yoon et al., 2001;levels achieved through use of the adenoviral vectors
would be very misleading if only a small number of  Puigserver et al., 2003). Altered insulin signaling incells
leading to impaired glucose-stimulated insulin secretioncells per islet were infected, the use of a GFP tag in the
adenoviral vectors gives confidence that the majority of has been demonstrated with animals lacking the insulin
receptor on the surface of  cells through genetic abla- cells in target islets were, in fact, successfully trans-
duced. The fact that the expression of certain genes tion (Kulkarni et al., 1999). In addition to relative insulin
deficiency, another possible cause for the elevation of(e.g., glucokinase and PDX-1) was markedly reduced by
PGC-1 expression is also not consistent with a severe PGC-1 in diabetes is the chronic exposure to elevated
levels of circulating free fatty acids that accompaniesoverexpression occurring in a relatively small number
of  cells per islet. obesity and diabetes. Alternatively, chronic, mild hyper-
glycemia or increased levels glucagon may contributeThat abnormal regulation of PGC-1 is a shared fea-
ture of several distinct models of diabetes suggests its to the elevation of PGC-1.
Since PGC-1 is a transcriptional coactivator, it isinvolvement in the common pathophysiological pathway
leading to  cell failure. While the primary stimulus that likely to affect  cell function through docking on a
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Figure 6. PGC-1 Alters Insulin Secretion from Transplanted Islets
(A) Rat islets were infected with GFP or PGC-1 adenovirus, and 600 islets were transplanted into STZ-induced diabetic mice (n  7 and 9
respectively). Nonfasting blood glucose levels and body weights were measured weekly. *p  0.05; **p  0.01 versus STZ-GFP.
(B) Plasma insulin levels were measured at 1, 2, and 4 weeks posttransplantation by radioimmunoassay. *p  0.05 versus STZ-GFP.
(C) Glucose tolerance test was performed at 4 weeks after transplantation by intraperitoneal injection of glucose and serial measurement of
blood glucose levels over a 2 hr period.
(D) Plasma insulin levels were measured during the glucose tolerance test at 4 weeks. *p  0.05; **p  0.01 versus STZ-GFP.
(E) Islet grafts were excised, and gene expression was analyzed by real-time RT-PCR. *p  0.05 versus STZ-GFP.
set of specific transcription factors bound to relevant 2002), accounting for some of the observed changes in
metabolic gene expression. HNF-4 is also a potentiallypromoters. Prominent among these is the forkhead fam-
ily member FOXO1. This factor has been shown to bind interesting target for PGC-1, but here the data is more
confusing. HNF-4 has been shown to be a positiveto the glucose-6-phosphatase promoter in liver, and
produces an impairment of insulin secretion when ele- modulator of  cell insulin secretion, and mutations in
HNF-4 are a cause of  cell dysfunction in one formvated in  cells. Most recently, we have shown that
PGC-1 binds directly to FOXO1 and increases its activ- of MODY diabetes (Yamagata et al., 1996). PGC-1 ex-
pression leads to a modest decrease in HNF-4 levels.ity on the glucose-6-phosphatase promoter in liver cells
(P.P. and B.M.S.; Puigserver et al., 2003). Coactivation However, PGC-1 also binds avidly to HNF-4 and
greatly increases its transcriptional activity (Yoon et al.,of FOXO1 in  cells may also lead to suppression of key
islet transcription factors such as PDX-1 (Nakae et al., 2001); how this could impact on  cell signaling is less
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5-GTGTATTCTCCTGCGGTCCG-3, (reverse) 5-CGAAGATAGCGAclear. Ultimately, the relative roles of various transcrip-
GAGTAGA-3; glucokinase (forward) 5-ATGTGCGTCAACACGGtion factors as potential targets for PGC-1 coactivation
AGTG-3, (reverse) 5-GGGTTCGCTGAGCTTTCATC-3; hexokinasemust be tested in islets, using both gain- and loss-of-
(forward) 5-AATCCTGGTGAAGATGGCCA-3, (reverse) 5-TGGCG
function approaches. The physiological role of PGC-1, GACACGTCACTAGTG-3; GLUT2 (forward) 5-GCTTTGCAGTAGG
a close homolog of PGC-1, should also be examined. CGGAATG-3, (reverse) 5-CAACGAGAGGCTGTTTGCAG-3; G3PDH
(forward) 5-AGGCCGACTGACTCCGTTCT-3, (reverse) 5-TTTGAAIt is of interest that PGC-1 did not increase expres-
ACGCCATTGCTCA-3; UCP2 (forward) 5-GTGTATTCTCCTGCGsion of mRNA for UCP-2 in cultured islets, especially
GTCCG-3, (reverse) 5-TGGCTATCATGGCCTGATCC-3; and TBPsince this coactivator has been shown to induce UCP-2
(forward) 5-ACCCTTCACCAATGACTCCTATG-3, (reverse) 5-TGAmRNA in cultured muscle cells (Wu et al., 1999), and
CTGCAGCAAATCGCTTGG-3.
UCP-2 has been shown to be a negative regulator of
glucose-stimulated insulin secretion (Zhang et al., 2001). Islet Isolation and Adenoviral Infections
Despite the lack of a direct effect at the gene expression Islets were isolated as previously described (Laybutt et al., 2002)
using an intraductal collagenase technique. Islets of similar sizelevel in cultured islets, it is still possible that PGC-1
(100–150m) were picked while viewed under a microscope, dividedmay regulate UCP-2 activity, perhaps by controlling the
into two groups, and were infected with adenovirus expressing ei-rate of mitochondrial generation of reactive oxygen spe-
ther GFP or PGC-1. Virus-treated islets were maintained in 10%
cies, an effector recently shown to control UCP-2 activ- fetal bovine serum (FBS) (Hyclone)-RPMI (Cellgro) at 37	C with 5%
ity (Echtay et al., 2002). Furthermore, the data from islet CO2%/95% room air. Glucose-stimulated insulin secretion assays
transplantation studies indicate that UCP-2 mRNA is were performed 48–72 hr after infection, at which time the efficiency
of adenoviral transduction was also determined by fluorescencemoderately induced in vivo following chronic elevation
confocal microscopy using the Zeiss LSM microscope (Carl Zeiss).of PGC-1 in islets. The role of PGC-1 as a regulator
The size of the islets and the number of cells per islet were compara-of  cell UCP-2 function requires more study.
ble between the two groups, without evidence of increased apopto-
The present findings raise the possibility that PGC-1 sis in one particular group.
may serve as a target in the  cell for treatment of
diabetes. To this end, identification of the mechanism Islet Perifusion Studies
by which PGC-1 is induced incells of diabetic animals Groups of 30 islets were sandwiched between two layers of Cyto-
dex-3 microcarrier beads (Sigma, St. Louis, MO) in a column of 1will be of particular interest. Also of importance will be
cm diameter and 1.3 cm height. They were perifused (Cunninghamdetermination of the specific transcription factors
et al., 1996) with a HEPES-buffered Krebs salt solution containingthrough which PGC-1 achieves the suppression of in-
119 mM NaCl, 4.6 mM KCl, 1 mM MgSO4, 0.15 mM Na2HPO4, 0.4sulin secretion. Inhibition of those key docking events mM KH2PO4, 25 mM NaHCO3, 2 mM CaCl2, 20 mM HEPES, pH 7.4,
may reverse certain aspects of defective  cell function 0.05% (w/v) BSA (fraction V; Sigma), and the designated concentra-
in diabetes. tions of glucose. Islets were perifused at a gravity flow rate of 0.3
ml/min for 30 min with a basal concentration of 3 mM glucose prior
to collection. Eluted fractions were then collected every 30 s. At aExperimental Procedures
predetermined time point, glucose concentration was increased
from 3 to 16.7 mM. Temperature was maintained at 37	C throughout.Real-Time RT-PCR
Samples were assayed for insulin by radioimmunoassay (Linco Re-Total RNA was prepared from cells or from tissues with Trizol (Life
search).Technologies) following the manufacturer’s instructions. 1 g of
total RNA was transferred to 100 l cDNA synthesis reactions con-
Batch Measurement of Glucose-Stimulatedtaining 1
 TaqMan RT buffer (Perkin Elmer Biosystems), 5.5 mM
Insulin Secretion from IsletsMgCl2, 500 M dNTPs, 2.5 M random hexamers, 0.4 U/l RNase
Islets were washed in HEPES-buffered Krebs salt solution with 2%inhibitor, and 1.25 U/l MultiScribe Reverse Transcriptase (Perkin
BSA and were pelleted in 15 ml centrifuge tubes (40 islets per tube).Elmer Biosystems). The reactions were incubated for 10 min at 25	C,
After a 15 min incubation in basal Krebs buffer (2% BSA, 3 mMfor 30 min at 48	C, followed by 5 min at 95	C. PCR reactions were
glucose) at 37	C, basal or stimulation buffer was added to eachthen carried out in a volume of 50 l containing 5 l of cDNA tem-
tube, and the islets were incubated for 1 hr at 37	C. Supernatantsplate, 300 nM of each primer, and 1
 SYBR Green PCR Master Mix
were removed and assayed for insulin content by ELISA (Crystal(Perkin Elmer Biosystems). Incubation steps were at 50	C for 2 min
Chem) using a rat insulin standard. The islets were extracted in acidand at 95	C for 10 min, followed by 40 cycles of switching between
ethanol at 4	C and assayed for insulin content by ELISA.95	C for 15 s and 60	C for 1 min. The products were detected with
the ABI Prism 7700 Sequence Detector (Perkin Elmer Biosystems)
Western Blot Analysisand the threshold cycle values (CT) were determined as a measure
Islets were lysed in a buffer containing 100 mM Tris (pH 8.5), 250of the cycle number at which a statistically significant increase in
mM NaCl, 1% NP-40, 1 mM EDTA, protease inhibitors (Boehringerfluorescence intensity is first detected. The RNA samples were run
Mannheim), and 0.1% phenylmethylsulfonyl fluoride, and were cen-in duplicates or triplicates for the cDNA synthesis and in the follow-
trifuged at 14,000 rpm for 10 min to remove particulate matter.ing PCR amplifications. The cDNA synthesis step included a control
Proteins were separated by SDS-PAGE, transferred to immobilin Preaction without the reverse transcriptase, and the PCR step in-
membrane (Millipore), and were probed with polyclonal antiseracluded a control reaction without the template to rule out contamina-
against PGC-1 or monoclonal anti--tubulin antibody (Boehringertion and/or genomic amplification. In addition, the TATA box binding
Mannheim).protein (TBP) gene was used as an endogenous control to account
for possible variations due to differences in initial RNA quality and
Islet Extraction and ATP Measurementsthe efficiency of the cDNA synthesis reaction. The abundance of
Islets were pelleted, extracted in 30–50 l of 0.1 M NaOH/0.5 mMthe amplified DNA was then determined from the CT values and was
EDTA, incubated at 60	C for 20 min, and stored at 80	C. The ATPnormalized to the value for the control gene TBP to yield the relative
concentrations were determined using a luciferin-based lumino-abundance. When comparing samples from two or more experimen-
metric assay (Ronner et al., 1999).tal groups, the relative abundance values were normalized to the
average relative abundance for the control group and the resulting
ratios were presented in figures. The oligonucleotide primers were Electrophysiology
Mouse pancreatic  cells were infected with either Ad PGC-1 oras follows: PGC-1 (forward) 5-GGCCCGGTACAGTGAGTGTT-3,
(reverse) 5-GCACTGAGGACTTGCTGAGTT-3; G6Pase (forward) Ad GFP and cultured for 48–72 hr on coverslips. Cells expressing
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the GFP marker gene were selected for membrane potential re- Deeney, J.T., Prentki, M., and Corkey, B.E. (2000). Metabolic control
of -cell function. Semin. Cell Dev. Biol. 11, 267–275.cordings by using the perforated-patch variant of the whole-cell
patch-clamp recording technique. Pipettes were pulled from boro- DeFronzo, R.A. (1997). Pathogenesis of type 2 diabetes: metabolic
silicate glass capillaries (Hilgenberg, Malsfeld, Germany) on a hori- and molecular implications for identifying diabetes genes. Diabetes
zontal programmable puller (DMZ Universal Puller; Zeitz-Instru- Rev. 5, 177–269.
mente, Augsburg, Germany). Typical electrode resistance was 2–4
Echtay, K.S., Roussel, D., St-Pierre, J., Jekabsons, M.B., Cadenas,
M. Electrodes were filled with 76 mM K2SO4, 1 mM MgCl2, 10 S., Stuart, J.A., Harper, J.A., Roebuck, S.J., Morrison, A., Pickering,
mM KCl, 10 mM NaCl, and 10 mM HEPES (pH 7.35), as well as
S., et al. (2002). Superoxide activates mitochondrial uncoupling pro-
amphotericin B (0.24 mg/ml) to permeabilize the cell membrane and
teins. Nature 415, 96–99.
allow low-resistance electrical access without breaking the patch.
Efrat, S., Leiser, M., Wu, Y.J., Fusco-DeMane, D., Emran, O.A., Sur-The cells were bathed in a solution containing 138 mM NaCl, 5.6
ana, M., Jetton, T.L., Magnuson, M.A., Weir, G., and Fleischer, N.mM KCl, 2.6 mM CaCl2, 1.2 mM MgCl2, 5 mM HEPES, and 3 mM
(1994). Ribozyme-mediated attenuation of pancreatic -cell glucoki-glucose (pH 7.4) for 1 hr before membrane potential registration.
nase expression in transgenic mice results in impaired glucose-Membrane potential was recorded during perifusion with 3 and 16.7
induced insulin secretion. Proc. Natl. Acad. Sci. USA 91, 2051–2055.mM glucose in current-clamp mode with an Axopatch 200 amplifier
(Axon Instruments, Foster City, CA). All recordings were made at Evans, A.J., and Krentz, A.J. (2001). Insulin resistance and -cell
34	C. dysfunction as therapeutic targets in type 2 diabetes. Diabetes
Obes. Metab. 3, 219–229.
Fabregat, M.E., Novials, A., Giroix, M.H., Sener, A., Gomis, R., andIslet Transplantation
Male nude Swiss mice were made diabetic by intraperitoneal injec- Malaisse, W.J. (1996). Pancreatic islet mitochondrial glycerophos-
phate dehydrogenase deficiency in two animal models of non-insu-tion of streptozotocin (STZ) (250 mg/kg) as previously described
(Kaneto et al., 2002). Freshly isolated rat islets were infected with lin-dependent diabetes mellitus. Biochem. Biophys. Res. Commun.
220, 1020–1023.adenovirus expressing either GFP or PGC-1, maintained in culture
for 2 days, and 600 islets were transplanted under kidney capsules Froguel, P., Vaxillaire, M., Sun, F., Velho, G., Zouali, H., Butel, M.O.,
of the diabetic mice as described (Kaneto et al., 2002). Following Lesage, S., Vionnet, N., Clement, K., Fougerousse, F., et al. (1992).
transplantation, nonfasting blood glucose levels and body weights Close linkage of glucokinase locus on chromosome 7p to early-
were measured weekly. Four weeks after transplantation, glucose onset non-insulin-dependent diabetes mellitus. Nature 356,
tolerance test was performed. Blood samples were collected into 162–164.
capillary tubes and plasma insulin determined by radioimmunoassay
Fulceri, R., Kardon, T., Banhegyi, G., Pralong, W.F., Gamberucci, A.,(Linco Research). Also 4 weeks after transplantation, islet grafts
Marcolongo, P., and Benedetti, A. (2000). Glucose-6-phosphatase inwere excised under methoxyflurane anesthesia and lysed in Trizol
the insulin secreting cell line INS-1. Biochem. Biophys. Res. Com-(Life Technologies) for real-time RT-PCR or semiquantitative RT-
mun. 275, 103–107.PCR as previously described (Kaneto et al., 2002).
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Statistical Analysis
regulates hepatic gluconeogenesis via the co-activator PGC-1. Na-
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ture 413, 179–183.
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